Schizophrenia affects approximately 24 million people or 1 in 300 people (0.32%) worldwide and is frequently associated with significant distress and impairment in personal, family, social, educational, occupational, and other important areas of life.
That is why Tandem Clinical Research is looking for volunteers with schizophrenia for a study of an investigational medication designed to manage symptoms safely. To qualify, you must